The Global Drug Discovery Informatics Market is poised for growth due to increased investments in R&D, big data's role in ...
The North America Biotechnology Market is set to skyrocket, reaching US$ 1.59 trillion by 2033 from US$ 532.72 billion in ...
New research reveals feminising hormone therapy significantly alters blood proteins in transgender women, en route to ...
Proteomics International Laboratories Ltd has announced the quotation of 50,000 fully paid ordinary securities on the Australian Securities Exchange (ASX) under the code PIQ. This move is part of the ...
New tools that create ultra-precise maps of our tissues are transforming our ability to diagnose and cure once-fatal ...
US Medicare Sets Reimbursement Price For Promarkerd DKD Test. Proteomics International Laboratories Ltd (ASX:PIQ) (OTCMKTS:PIQLF), a pioneer in precision diagnostics, is pleased to announce that the U ...
Proteomics International Confirms US Reimbursement Price for ProMarkerD Diabetic Kidney Disease Test
Proteomics International Laboratories (ASX: PIQ) has announced that the US Centres for Medicare & Medicaid Services has set a ...
Satish Kumar Nalluri Recognized For Strengthening U.S. Biotechnology Manufacturing Through MES Innovation. EINPresswire / -- Senior Developer in Manufacturing Execution Systems (MES) and automation Sa ...
The latest announcement is out from Proteomics International Laboratories Ltd. ( ($AU:PIQ) ). Proteomics International Laboratories Ltd announced ...
Proteomics International Laboratories Ltd. ( ($AU:PIQ) ) has shared an update. Proteomics International Laboratories Ltd announced the issuance of ...
Nordic Capital aims to drive value at Evosep primarily through organic growth, citing the “significant” potential within the ...
EVE is a deep generative model combining evolutionary and human population data to estimate variant deleteriousness on a proteome-wide scale.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results